Aeterna Zentaris Files May 2024 6-K Report

Ticker: CSCIF · Form: 6-K · Filed: May 16, 2024 · CIK: 1113423

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, regulatory-filing

TL;DR

Aeterna Zentaris filed its monthly 6-K, standard foreign issuer update.

AI Summary

Aeterna Zentaris Inc. filed a Form 6-K on May 15, 2024, for the month of May 2024, reporting as a foreign private issuer. The company, previously known as AETERNA LABORATORIES INC, is incorporated in A6 and has a fiscal year end of December 31. Their principal executive office is located in Toronto, ON, Canada.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding the company's status as a foreign private issuer.

Risk Assessment

Risk Level: low — This filing is a routine report and does not contain significant new financial or operational information that would immediately impact risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange on which its securities are traded, or distributes or is required to distribute to its security holders.

What is the filing date of this Form 6-K?

This Form 6-K was filed on May 15, 2024.

What is the reporting period for this Form 6-K?

This Form 6-K is for the month of May 2024.

What was Aeterna Zentaris Inc. formerly known as?

Aeterna Zentaris Inc. was formerly known as AETERNA LABORATORIES INC.

Where is Aeterna Zentaris Inc.'s principal executive office located?

Aeterna Zentaris Inc.'s principal executive office is located at c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7.

Filing Stats: 319 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2024-05-15 19:02:01

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38064 Aeterna Zentaris Inc. (Translation of registrant's name into English) c/o Norton Rose Fulbright Canada, LLP , 222 Bay Street , Suite 3000, PO Box 53 , Toronto ON M5K 1E7 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Exhibits 99.1 and 99.2, included with this report on Form 6-K are hereby incorporated by reference into the Registrant's Registration report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished. DOCUMENTS INDEX Exhibit Description 99.1 Aeterna Zentaris' Condensed Interim Consolidated Financial Statements – First Quarter 2024 (Q1) 99.2 Aeterna Zentaris' Management's Discussion and Analysis of Financial Condition and Results of Operations – First Quarter 2024 (Q1) 99.3 Certification of the Chief Executive Officer pursuant to National Instrument 52-109 99.4 Certification of the Principal Financial Officer pursuant to National Instrument 52-109 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AETERNA ZENTARIS INC. Date: May 15, 2023 By: /s/ Klaus Paulini Klaus Paulini President and Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing